Market Overview

UPDATE: Morgan Stanley Cuts PT to $9 on Aeropostale; Structurally Challenged

Share:
Related ARO
Mid-Afternoon Market Update: Dow Falls 100 Points; Sarepta Therapeutics Shares Drop Following Release of FDA Briefing Documents on Eteplirsen
Aeropostale's Stock Plunges Following Bloomberg Report Company Is Preparing To Declare Bankruptcy

Morgan Stanley reiterated its Underweight rating on Aeropostale (NYSE: ARO) and lowered its price target from $11 to $9.

Morgan Stanley noted, "Disappointing 4Q guidance suggests ARO's business remains under pressure. The market likely believes consensus's FY12 ~5% EBIT margin is a trough figure, but we think it represents the new normal. Our FY13 EPS estimate is 21% below consensus and we see ~30% stock price downside."

Aeropostale closed at $14.12 on Wednesday.

Latest Ratings for ARO

DateFirmActionFromTo
Aug 2015Wolfe ResearchInitiates Coverage onPeer Perform
Jul 2015UBSDowngradesNeutralSell
May 2015FBR CapitalMaintainsMarket Perform

View More Analyst Ratings for ARO
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (ARO)

View Comments and Join the Discussion!